Home > Publications database > Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8. > print |
001 | 179247 | ||
005 | 20240229145537.0 | ||
024 | 7 | _ | |a 10.1126/sciadv.abh4050 |2 doi |
024 | 7 | _ | |a pmid:35319989 |2 pmid |
024 | 7 | _ | |a altmetric:125197016 |2 altmetric |
037 | _ | _ | |a DKFZ-2022-00529 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Walle, Thomas |0 P:(DE-He78)51635089578f68fc9efdb61e6a760b64 |b 0 |e First author |u dkfz |
245 | _ | _ | |a Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8. |
260 | _ | _ | |a Washington, DC [u.a.] |c 2022 |b Assoc. |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1648641779_12909 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:E055#LA:E055# |
520 | _ | _ | |a Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8-dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56dim-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56dim NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy. |
536 | _ | _ | |a 315 - Bildgebung und Radioonkologie (POF4-315) |0 G:(DE-HGF)POF4-315 |c POF4-315 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Kraske, Joscha |0 P:(DE-He78)7fb0841f5e88928308e29474e3170818 |b 1 |u dkfz |
700 | 1 | _ | |a Liao, Boyu |0 P:(DE-He78)c3341cb95b840ce8a9365b013a464e41 |b 2 |u dkfz |
700 | 1 | _ | |a Lenoir, Bénédicte |0 P:(DE-He78)4671d97058e8d2ddb314e6be4de0c403 |b 3 |u dkfz |
700 | 1 | _ | |a Timke, Carmen |0 0000-0003-0256-6625 |b 4 |
700 | 1 | _ | |a von Bohlen Und Halbach, Emilia |0 P:(DE-He78)10877b4f46992f46a4fafc3e16e40eb3 |b 5 |
700 | 1 | _ | |a Tran, Florian |0 0000-0002-3735-9872 |b 6 |
700 | 1 | _ | |a Griebel, Paul |0 0000-0001-5671-8183 |b 7 |
700 | 1 | _ | |a Albrecht, Dorothee |0 P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa |b 8 |u dkfz |
700 | 1 | _ | |a Ahmed, Azaz |0 P:(DE-He78)bac8c2c56238485ecf0475ff14438430 |b 9 |u dkfz |
700 | 1 | _ | |a Suarez-Carmona, Meggy |0 P:(DE-He78)7eaaf5131f5096c7ff7de12dde4ceca5 |b 10 |u dkfz |
700 | 1 | _ | |a Jiménez-Sánchez, Alejandro |0 0000-0003-1879-7057 |b 11 |
700 | 1 | _ | |a Beikert, Tizian |0 P:(DE-He78)53d20e6d4d85019eeb3f21bb93ae62fa |b 12 |u dkfz |
700 | 1 | _ | |a Tietz-Dahlfuß, Alexandra |0 0000-0003-1489-3885 |b 13 |
700 | 1 | _ | |a Menevse, Ayse Nur |b 14 |
700 | 1 | _ | |a Schmidt, Gabriele |0 P:(DE-He78)e8868a5fc184fe2e756d7e11ad1ac748 |b 15 |u dkfz |
700 | 1 | _ | |a Brom, Manuela |0 P:(DE-He78)2e781085118732ec90737b79c643a9d1 |b 16 |u dkfz |
700 | 1 | _ | |a Pahl, Jens H W |b 17 |
700 | 1 | _ | |a Antonopoulos, Wiebke |b 18 |
700 | 1 | _ | |a Miller, Matthias |b 19 |
700 | 1 | _ | |a Perez, Ramon Lopez |0 0000-0002-6876-2074 |b 20 |
700 | 1 | _ | |a Bestvater, Felix |0 P:(DE-He78)89e155931400aa7bb80b79b6be41f979 |b 21 |u dkfz |
700 | 1 | _ | |a Giese, Nathalia A |b 22 |
700 | 1 | _ | |a Beckhove, Philipp |b 23 |
700 | 1 | _ | |a Rosenstiel, Philip |0 0000-0002-9692-8828 |b 24 |
700 | 1 | _ | |a Jäger, Dirk |0 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1 |b 25 |u dkfz |
700 | 1 | _ | |a Strobel, Oliver |b 26 |
700 | 1 | _ | |a Pe'er, Dana |0 0000-0002-9259-8817 |b 27 |
700 | 1 | _ | |a Halama, Niels |0 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601 |b 28 |u dkfz |
700 | 1 | _ | |a Debus, Jürgen |b 29 |
700 | 1 | _ | |a Cerwenka, Adelheid |b 30 |
700 | 1 | _ | |a Huber, Peter |0 P:(DE-He78)3291aaac20f3d603d96744c1f0890028 |b 31 |e Last author |u dkfz |
773 | _ | _ | |a 10.1126/sciadv.abh4050 |g Vol. 8, no. 12, p. eabh4050 |0 PERI:(DE-600)2810933-8 |n 12 |p eabh4050 |t Science advances |v 8 |y 2022 |x 2375-2548 |
909 | C | O | |o oai:inrepo02.dkfz.de:179247 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)51635089578f68fc9efdb61e6a760b64 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)7fb0841f5e88928308e29474e3170818 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)c3341cb95b840ce8a9365b013a464e41 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)4671d97058e8d2ddb314e6be4de0c403 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)10877b4f46992f46a4fafc3e16e40eb3 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)bac8c2c56238485ecf0475ff14438430 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)7eaaf5131f5096c7ff7de12dde4ceca5 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)53d20e6d4d85019eeb3f21bb93ae62fa |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 0000-0003-1489-3885 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)e8868a5fc184fe2e756d7e11ad1ac748 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)2e781085118732ec90737b79c643a9d1 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 0000-0002-6876-2074 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)89e155931400aa7bb80b79b6be41f979 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 28 |6 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 31 |6 P:(DE-He78)3291aaac20f3d603d96744c1f0890028 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-315 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Bildgebung und Radioonkologie |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version) |0 LIC:(DE-HGF)CCBYNCNV |2 V:(DE-HGF) |b DOAJ |d 2021-01-30 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-30 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-30 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2021-01-30 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2021-01-30 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SCI ADV : 2021 |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-09-20T13:50:30Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-09-20T13:50:30Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2021-09-20T13:50:30Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-08 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2022-11-08 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b SCI ADV : 2021 |d 2022-11-08 |
920 | 2 | _ | |0 I:(DE-He78)E055-20160331 |k E055 |l E055 KKE Translationale Radioonkologie |x 0 |
920 | 0 | _ | |0 I:(DE-He78)E055-20160331 |k E055 |l E055 KKE Translationale Radioonkologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)E055-20160331 |k E055 |l E055 KKE Translationale Radioonkologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 1 |
920 | 1 | _ | |0 I:(DE-He78)D120-20160331 |k D120 |l D120 Angewandte Tumor-Immunität |x 2 |
920 | 1 | _ | |0 I:(DE-He78)D240-20160331 |k D240 |l Translationale Immuntherapie |x 3 |
920 | 1 | _ | |0 I:(DE-He78)W210-20160331 |k W210 |l Lichtmikroskopie |x 4 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)E055-20160331 |
980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
980 | _ | _ | |a I:(DE-He78)D120-20160331 |
980 | _ | _ | |a I:(DE-He78)D240-20160331 |
980 | _ | _ | |a I:(DE-He78)W210-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|